Associations of TNF-Α -308 and -238 Polymorphisms with Inflammatory Bowel Disease: A Case-Control Study and Meta-Analysis of Published Data

  • Shirin Moosavi Snyder Institute for Chronic Diseases, University of Calgary, Alberta, Canada
  • Aaron Shanker Department of Internal Medicine, Texas Tech University Health Sciences Center, El Paso, Texas, USA
  • Maryam Sadr Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Samaneh Soltani Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Sepideh Shahkarami Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Munich, Germany
  • Elham Farhadi Molecular Immunology Research Center, Tehran University of Medical Sciences, Tehran, Iran
  • Nasser Ebrahimi Daryani Division of Gastroenterology, Department of Medicine, Tehran University of Medical Sciences, Tehran, Iran
  • Behnoud Baradaran Noveiry Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, Baltimore, Maryland, USA
  • Farnaz Najmi Varzaneh Department of Radiology, Yale University, New Haven, Connecticut, USA
  • Mohammad Bashashati Division of Gastroenterology, Department of Medicine, Dell Medical School at UT Austin, Austin, TX, USA
  • Nima Rezaei Research Center for Immunodeficiencies, Children’s Medical Center Hospital, Tehran University of Medical Sciences, Tehran, Iran
Keywords: Inflammatory Bowel Disease; Ulcerative Colitis; Crohn's Disease; Allele Frequency; Polymor- phisms; Meta-Analysis

Abstract

Background: Inflammatory bowel disease (IBD) is a chronic relapsing-remitting inflammatory disease of the intestinal tract. Tumor necrosis factor-alpha (TNF-α) signaling plays a major role in the pathogenesis of IBD and is commonly targeted for therapeutic purposes. Results on the contribution of TNF-α -308 and -238 single nucleotide polymorphisms (SNP) to the susceptibility to IBD have been contradictory in differ- ent populations.

Methods: Allele frequency and genotype status of TNF-α -308 and -238 SNPs were investigated in 75 un- related patients with IBD [40 Crohn’s disease (CD) and 35 ulcerative colitis (UC)] and 140 healthy controls by polymerase chain reaction with sequence-specific primers (PCR-SSP). We also conducted a systematic review and meta-analysis of the published reports.

Results: TNF-α -238 GG was detected at a higher frequency in CD and UC. TNF-α -308 GG was more frequently detected in UC compared to control. There was no significant association between TNF-α -238 or -308 gene polymorphisms and patients’ demography (i.e., gender and age) or disease phenotype (i.e., extraintestinal manifestations, treatment, activity index, age at onset, and duration of the disease). In the meta-analysis, TNF-α -238 (AA/AG) genotype tended to be less frequent in patients with UC compared to healthy controls. There was no association between TNF-α -238 gene polymorphisms (AA/AG or GG genotypes) and either form of IBD.

Conclusion: TNF-α -308 and -238 SNPs are associated with IBD in Iranian patients. TNF-α -308 AA gen- otype is positively correlated with UC in this meta-analysis.

 

Published
2025-02-28
Section
Articles